Robert Mittendorff

B Capital Group is a venture capital firm that backs global entrepreneurs in the field of information technology.

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

Raised $268,000,000.00 from NEXTBio Capital, RTW Investments, Longwood Fund, RA Capital Management, Sectoral Asset Management, Marshall Wace, Avego Bioscience Capital, SymBiosis, FemHealth Ventures and Andera Partners.

Nuvig Therapeutics is a biotechnology company developing therapies to induce natural mechanisms to restore immune homeostasis.

Raised $208,000,000.00 from Norwest Venture Partners, Blue Owl, Mission BioCapital, Lotte, Cowen Healthcare Investments, Bristol-Myers Squibb, Alexandria Venture Investments, Sanofi Ventures, Global BioAccess Fund and Abrdn.

Nalu Medical is a medical technology company that develops innovative solutions for patients with chronic neuropathic pain.

Raised $200,915,367.00 from Pura Vida Investments, Aperture Venture Partners, Advent Life Sciences, Longitude Capital, B Capital, Decheng Capital, Endeavour Vision, Novo Holdings, Gilde Healthcare and MVM Life Science Partners.

Capital Rx is a healthtech platform that provides pharmacy benefit management solutions.

Raised $252,960,628.00 from Prime Therapeutics.

The company manufactures and sells the aprevo™ digital-to-device 3-D printed implant system for lumbar spine surgery.

Raised $96,985,000.00 from U.S. Venture Partners and B Capital.

Lively is a modern Health Savings Account (HSA) platform for employers and individuals.

Raised $122,200,000.00 from B Capital, Costanoa Ventures and Titanium Ventures.

HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment.

Raised $210,000,000.00 from Pavilion Capital, Revelation Partners, SR One, LSP BioVentures, Monashee Investment Management, B Capital, Atlas Venture, Sofinnova Partners, CaaS Capital Management and Pivotal bioVenture Partners.

Triumvira Immunologics is an immunotherapy company that develops novel T cell therapies for cancer.

Raised $100,000,000.00 from Myeloma Investment Fund, Multiple Myeloma Research Foundation, Northpond Ventures, Leaps by Bayer, B Capital, ATEM Capital Fund LP, Northpond Ventures, Bloom Burton & Co., Centre for Commercialization of Cancer Immunotherapy and Leaps by Bayer.